Trademark: 90705905
Word
EXOTRU
Status
Pending
Status Code
733
Status Date
Monday, March 25, 2024
Serial Number
90705905
Mark Type
4000
Filing Date
Wednesday, May 12, 2021
Published for Opposition
Tuesday, March 1, 2022
Trademark Owner History
Exosome Diagnostics, Inc. - Owner At Publication
Classifications
5 Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids to diagnose and predict kidney rejection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes to diagnose and predict kidney rejection
44 Medical testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes in the field of kidney transplant; liquid biopsy testing for medical purposes
Trademark Events
Mar 26, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 25, 2024
Sou Extension 4 Granted
Mar 25, 2024
Sou Extension 4 Filed
Mar 25, 2024
Sou Teas Extension Received
Oct 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 18, 2023
Sou Extension 3 Granted
Oct 18, 2023
Sou Extension 3 Filed
Oct 18, 2023
Sou Teas Extension Received
May 8, 2023
Teas Change Of Correspondence Received
May 8, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
May 8, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
May 8, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2023
Sou Extension 2 Granted
Mar 28, 2023
Sou Extension 2 Filed
Mar 28, 2023
Sou Teas Extension Received
Oct 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 25, 2022
Sou Extension 1 Granted
Oct 25, 2022
Sou Extension 1 Filed
Oct 25, 2022
Sou Teas Extension Received
Apr 26, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 1, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 1, 2022
Published For Opposition
Feb 9, 2022
Notification Of Notice Of Publication E-Mailed
Jan 24, 2022
Approved For Pub - Principal Register
Jan 24, 2022
Examiner's Amendment Entered
Jan 24, 2022
Notification Of Examiners Amendment E-Mailed
Jan 24, 2022
Examiners Amendment E-Mailed
Jan 24, 2022
Examiners Amendment -Written
Jan 20, 2022
Assigned To Examiner
Aug 11, 2021
New Application Office Supplied Data Entered
May 15, 2021
New Application Entered
JOURNAL OF HEMATOLOGY ONCOLOGY PHARMACY
DIGICAST
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov